BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18394001)

  • 1. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
    Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
    Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
    Sommerer C; Giese T; Schmidt J; Meuer S; Zeier M
    Transplantation; 2008 Jan; 85(1):15-21. PubMed ID: 18192906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
    Giese T; Zeier M; Schemmer P; Uhl W; Schoels M; Dengler T; Buechler M; Meuer S
    Transplantation; 2004 Feb; 77(3):339-44. PubMed ID: 14966405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.
    Sommerer C; Konstandin M; Dengler T; Schmidt J; Meuer S; Zeier M; Giese T
    Transplantation; 2006 Nov; 82(10):1280-5. PubMed ID: 17130775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of nuclear factor of activated T-cell-regulated gene expression in de novo and long-term liver transplant recipients treated with cyclosporine a.
    Herden U; Kromminga A; Hagel C; Hartleb J; Nashan B; Sterneck M; Fischer L
    Ther Drug Monit; 2011 Apr; 33(2):185-91. PubMed ID: 21383649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
    Sommerer C; Morath C; Giese T; Meuer S; Zeier M
    Transplant Proc; 2008 Jun; 40(5):1416-8. PubMed ID: 18589120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic cyclosporine A-monitoring: relation of gene expression in lymphocytes to cyclosporine blood levels in cardiac allograft recipients.
    Konstandin MH; Sommerer C; Doesch A; Zeier M; Meuer SC; Katus HA; Dengler TJ; Giese T
    Transpl Int; 2007 Dec; 20(12):1036-43. PubMed ID: 17850236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
    Sommerer C; Zeier M; Meuer S; Giese T
    Transplantation; 2010 Jun; 89(11):1417-23. PubMed ID: 20463649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic monitoring by residual NFAT-regulated gene expression in stable pediatric liver transplant recipients.
    Billing H; Breil T; Schmidt J; Tönshoff B; Schmitt CP; Giese T; Engelmann G
    Pediatr Transplant; 2012 Mar; 16(2):187-94. PubMed ID: 22360403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic monitoring of cyclosporin A reveals risk of opportunistic infections and malignancies in renal transplant recipients 65 years and older.
    Sommerer C; Schnitzler P; Meuer S; Zeier M; Giese T
    Ther Drug Monit; 2011 Dec; 33(6):694-8. PubMed ID: 22105585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremia.
    Sommerer C; Zeier M; Czock D; Schnitzler P; Meuer S; Giese T
    Ther Drug Monit; 2011 Aug; 33(4):373-9. PubMed ID: 21743376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation.
    Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
    Transpl Infect Dis; 2014 Jun; 16(3):379-86. PubMed ID: 24666466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitors.
    Giese T; Zeier M; Meuer S
    Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv55-60. PubMed ID: 15240851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients.
    Billing H; Giese T; Sommerer C; Zeier M; Feneberg R; Meuer S; Tönshoff B
    Pediatr Transplant; 2010 Nov; 14(7):844-51. PubMed ID: 20602720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine-induced gingival overgrowth correlates with NFAT-regulated gene expression: a pilot study.
    Dannewitz B; Kruck EM; Staehle HJ; Eickholz P; Giese T; Meuer S; Kaever V; Zeier M; Sommerer C
    J Clin Periodontol; 2011 Nov; 38(11):984-91. PubMed ID: 21883361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine A.
    Sommerer C; Zeier M; Meuer S; Giese T
    Clin Nephrol; 2015 Sep; 84(3):165-72. PubMed ID: 26226950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
    Büchler M; Chadban S; Cole E; Midtvedt K; Thervet E; Prestele H; Keown P
    Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
    Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
    Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring immunosuppression with measures of NFAT decreases cancer incidence.
    Giese T; Sommerer C; Zeier M; Meuer S
    Clin Immunol; 2009 Sep; 132(3):305-11. PubMed ID: 19398376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.